6896-5cloZAPine [Mass/volume] in Serum or PlasmaActive
Term Description
Per ARUP, clozapine levels are used to evaluate toxicity and monitor therapeutic drug levels. 100 ng/mL is the minimum therapeutic threshold, and levels > 1200 ng/mL increase the likelihood of adverse effects such as seizures.
Source: Regenstrief LOINC
Part Descriptions
LP17236-8 cloZAPine
Clozapine (sold as Clozaril ®, Leponex ®, Fazaclo ®) was the first of the atypical antipsychotics to be developed. It was approved by the United States Food and Drug Administration (FDA) in 1989 and is the only FDA-approved medication indicated for treatment-resistant schizophrenia and for reducing the risk of suicidal behaviour in patients with schizophrenia.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Clozapine (Wikipedia)
LP17236-8 cloZAPine
A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent.
Source: National Library of Medicine, MeSH 2006
Fully-Specified Name
- Component
- cloZAPine
- Property
- MCnc
- Time
- Pt
- System
- Ser/Plas
- Scale
- Qn
- Method
Additional Names
- Short Name
- cloZAPine SerPl-mCnc
- Display Name
- cloZAPine [Mass/Vol]
- Consumer Name Alpha
- cloZAPine, Blood
Basic Attributes
- Class
- DRUG/TOX
- Type
- Laboratory
- First Released
- Version 1.0h(2)
- Last Updated
- Version 2.73
- Order vs. Observation
- Both
- Common US Lab Results Rank
- 2327
- Common Orders Rank
- 189
Member of these Panels
LOINC | Long Common Name |
---|---|
65632-2 | cloZAPine and Norclozapine panel - Serum or Plasma |
Member of these Groups
LG48379-8 | Clozapine| |
Language Variants Get Info
- zh-CNChinese (China)
- 氯氮平:
质量浓度: 时间点: 血清/血浆: 定量型: - nl-NLDutch (Netherlands)
- clozapine:
massa/volume: moment: serum of plasma: kwantitatief: - et-EEEstonian (Estonia)
- Klosapiin:
MCnc: Pt: S/P: Qn: - fr-BEFrench (Belgium)
- Clozapine:
Concentration de masse: Temps ponctuel: Sérum/Plasma: Quantitatif: - fr-CAFrench (Canada)
- Clozapine:
Concentration de masse: Temps ponctuel: Sérum/Plasma: Quantitatif: - fr-FRFrench (France)
- Clozapine:
Masse/Volume: Ponctuel: Sérum/Plasma: Numérique: - de-DEGerman (Germany)
- Clozapin:
Massenkonzentration: Zeitpunkt: Serum oder Plasma: Quantitativ: - it-ITItalian (Italy)
- Clozapina:
MCnc: Pt: Siero/Plasma: Qn: - ko-KRKorean (Korea, Republic of)
- 클로자핀:
질량농도: 검사시점: 혈청/혈장: 정량: - pt-BRPortuguese (Brazil)
- Clozapina:
MCnc: Pt: Sor/Plas: Qn: - ru-RURussian (Russian Federation)
- Клозапин:
МассКонц: ТчкВрм: Сыв/Плаз: Колич: - es-ARSpanish (Argentina)
- clozapina:
concentración de masa: punto en el tiempo: suero/plasma: cuantitativo: - es-MXSpanish (Mexico)
- clozapina:
Concentración de masa: Punto temporal: Suero o Plasma: Cuantitativo: - es-ESSpanish (Spain)
- Clozapina:
Concentración de masa: Punto temporal: Suero o Plasma: Qn: - tr-TRTurkish (Turkey)
- Klozapine:
KütlKons: Zmlı: Ser/Plaz: Kant:
Example Units
Unit | Source |
---|---|
ug/L | eCHN |
ng/mL | Example UCUM Units |
ng/mL | REGENSTRIEF |
LOINC FHIR® API Example - CodeSystem Request Get Info
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=6896-5
LOINC Copyright
Copyright © 2022 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright